Management of important adverse events associated with inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia Meeting Abstract
| Authors: | Kebriaei, P.; van Besien, K.; Cutler, C.; de Lima, M.; Giralt, S.; Lee, S.; Marks, D.; Merchant, A.; Stock, W.; Stelljes, M. |
| Abstract Title: | Management of important adverse events associated with inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia |
| Meeting Title: | 5th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 17 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Sep 13-16 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-09-01 |
| Start Page: | S261 |
| Language: | English |
| ACCESSION: | 124936339 |
| DOI: | 10.1016/j.clml.2017.07.027 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: ALL-142 -- Accession Number: 124936339 -- Entry Date: In Process -- Revision Date: 20170904 -- Publication Type: Article -- Supplement Title: Sep2017 Supplement 2 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20 |
